• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化伴或不伴液体潴留患者中γ变量血浆清除率与铬-乙二胺四乙酸尿血浆清除率的比较

Gamma-variate plasma clearance versus urinary plasma clearance of Cr-EDTA in patients with cirrhosis with and without fluid retention.

作者信息

Fuglsang Stefan, Henriksen Ulrik L, Hansen Hanne B, Bendtsen Flemming, Henriksen Jens H

机构信息

Department of Clinical Physiology and Nuclear Medicine, 239, Center for Functional and Diagnostic Imaging and Research, Copenhagen, Denmark.

Gastro Unit, Medical Division, 439, Hvidovre Hospital and Medical and Health Faculty, University of Copenhagen, Copenhagen, Denmark.

出版信息

Clin Physiol Funct Imaging. 2017 Nov;37(6):588-595. doi: 10.1111/cpf.12336. Epub 2016 Jan 14.

DOI:10.1111/cpf.12336
PMID:26769593
Abstract

In patients with fluid retention, the plasma clearance of Cr-EDTA (Cl obtained by multiexponential fit) may overestimate the glomerular filtration rate (GFR). The present study was undertaken to compare a gamma-variate plasma clearance (Cl with the urinary plasma clearance of Cr-EDTA (Cl ) in patients with cirrhosis with and without fluid retention. A total of 81 patients with cirrhosis (22 without fluid retention, 59 with ascites) received a quantitative intravenous injection of Cr-EDTA followed by plasma and quantitative urinary samples for 5 h. Cl was determined from the injected dose relative to the plasma concentration-time area, obtained by a gamma-variate iterative fit. Cl and Cl were determined by standard technique. In patients without fluid retention, Cl , Cl and Cl were closely similar. The difference between Cl and Cl (Cl - Cl  = ΔCl) was mean -0·6 ml min  1·73 m . In patients with ascites, ΔCl was significantly higher (11·8 ml min  1·73 m , P<0·0001), but this value was lower than Cl - Cl (17·5 mL min  1·73 m , P<0·01). ΔCl increased with lower values of GFR (P<0·001). In conclusion, in patients with fluid retention and ascites Cl and Cl overestimates GFR substantially, but the overestimation is smaller with Cl . Although Cl may underestimate GFR slightly, patients with ascites should collect urine quantitatively to obtain a reliable measurement of GFR.

摘要

在存在液体潴留的患者中,铬标记乙二胺四乙酸(Cr-EDTA)的血浆清除率(通过多指数拟合得到的Cl)可能会高估肾小球滤过率(GFR)。本研究旨在比较肝硬化伴或不伴液体潴留患者中γ变量血浆清除率(Cl)与Cr-EDTA的尿血浆清除率(Cl)。总共81例肝硬化患者(22例无液体潴留,59例有腹水)接受了定量静脉注射Cr-EDTA,随后在5小时内采集血浆和定量尿液样本。通过γ变量迭代拟合从注射剂量相对于血浆浓度-时间曲线下面积确定Cl。通过标准技术测定Cl和Cl。在无液体潴留的患者中,Cl、Cl和Cl非常相似。Cl与Cl之间的差异(Cl - Cl = ΔCl)平均为-0·6 ml·min⁻¹·73 m²。在有腹水的患者中,ΔCl显著更高(11·8 ml·min⁻¹·73 m²,P<0·0001),但该值低于Cl - Cl(17·5 mL·min⁻¹·73 m²,P<0·01)。ΔCl随GFR值降低而增加(P<0·001)。总之,在有液体潴留和腹水的患者中,Cl和Cl会大幅高估GFR,但Cl的高估程度较小。尽管Cl可能会略微低估GFR,但有腹水的患者应定量收集尿液以获得可靠的GFR测量值。

相似文献

1
Gamma-variate plasma clearance versus urinary plasma clearance of Cr-EDTA in patients with cirrhosis with and without fluid retention.肝硬化伴或不伴液体潴留患者中γ变量血浆清除率与铬-乙二胺四乙酸尿血浆清除率的比较
Clin Physiol Funct Imaging. 2017 Nov;37(6):588-595. doi: 10.1111/cpf.12336. Epub 2016 Jan 14.
2
Total plasma clearance versus urinary plasma clearance of (51)Cr-EDTA in patients with cirrhosis with and without fluid retention.肝硬化伴或不伴液体潴留患者中(51)铬-乙二胺四乙酸的总血浆清除率与尿血浆清除率对比
Scand J Clin Lab Invest. 2015 Jan;75(1):64-72. doi: 10.3109/00365513.2014.980313. Epub 2014 Nov 20.
3
Conventional measurements of GFR using 51Cr-EDTA overestimate true renal clearance by 10 percent.使用51Cr-乙二胺四乙酸(51Cr-EDTA)对肾小球滤过率(GFR)进行的传统测量会使真实的肾脏清除率高估10%。
Eur J Nucl Med Mol Imaging. 2003 Jan;30(1):4-8. doi: 10.1007/s00259-002-1007-y. Epub 2002 Oct 26.
4
Mannitol clearance for the determination of glomerular filtration rate-a validation against clearance of Cr-EDTA.用于测定肾小球滤过率的甘露醇清除率——与铬标记乙二胺四乙酸清除率的对比验证
Clin Physiol Funct Imaging. 2018 Jan;38(1):10-16. doi: 10.1111/cpf.12374. Epub 2016 Jun 3.
5
The early plasma concentration of 51Cr-EDTA in patients with cirrhosis and ascites: a comparison of three models.肝硬化腹水患者51Cr-乙二胺四乙酸的早期血浆浓度:三种模型的比较
Nucl Med Commun. 2015 Apr;36(4):392-7. doi: 10.1097/MNM.0000000000000255.
6
Over-estimation of glomerular filtration rate by single injection [51Cr]EDTA plasma clearance determination in patients with ascites.通过单次注射[51Cr]乙二胺四乙酸血浆清除率测定法对腹水患者肾小球滤过率的高估。
Scand J Clin Lab Invest. 1980 May;40(3):279-84. doi: 10.3109/00365518009095579.
7
Reliability of ⁵¹Cr-EDTA plasma and urinary clearance as a measure of residual renal function in dialysis patients.⁵¹Cr-EDTA 血浆和尿清除率作为透析患者残余肾功能测量指标的可靠性。
Scand J Clin Lab Invest. 2011 Dec;71(8):663-9. doi: 10.3109/00365513.2011.619565. Epub 2011 Oct 13.
8
Comparison of simultaneous plasma clearance of Tc-DTPA and Cr-EDTA: can one tracer replace the other?Tc-DTPA 与 Cr-EDTA 同时血浆清除率的比较:一种示踪剂能否替代另一种?
Scand J Clin Lab Invest. 2019 Nov;79(7):463-467. doi: 10.1080/00365513.2019.1658217. Epub 2019 Sep 10.
9
Chromium-51-EDTA clearance in adults with a single-plasma sample.单份血浆样本检测成人的铬-51-乙二胺四乙酸清除率
J Nucl Med. 1998 Dec;39(12):2131-7.
10
Validation of Tikhonov adaptively regularized gamma variate fitting with 24-h plasma clearance in cirrhotic patients with ascites.腹水肝硬化患者 24 小时血浆清除率的 Tikhonov 自适应正则化伽马变量拟合验证。
Eur J Nucl Med Mol Imaging. 2011 Dec;38(12):2247-56. doi: 10.1007/s00259-011-1887-9. Epub 2011 Sep 1.